Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. - Wikidata - awgldk - TriplyDB

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

http://www.wikidata.org/entity/Q42219156

about

Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications Monitoring of the Immune Dysfunction in Cancer Patients Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.Lack of significant elevation of myeloid-derived suppressor cells in peripheral blood of chronically hepatitis C virus-infected individuals.Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.Arginase activity - a marker of disease status in patients with visceral leishmaniasis in ethiopia Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Analysis of monocytic and granulocytic myeloid-derived suppressor cells subsets in patients with hepatitis C virus infection and their clinical significance Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses.Complexity and challenges in defining myeloid-derived suppressor cells Myeloid derived suppressor cells in chronic myeloid leukemia.Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells.Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis.Trial watch: Prognostic and predictive value of the immune infiltrate in cancer Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer.Arginase-1-dependent promotion of TH17 differentiation and disease progression by MDSCs in systemic lupus erythematosus.Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules.Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.Immunologic microenvironment and personalized treatment in multiple myeloma.Myeloid-derived suppressor cells in cancer: recent progress and prospects.Myeloid-derived suppressor cells in glioma.Signaling pathways involved in MDSC regulation.Immunoregulatory activity of adenosine and its role in human cancer progression.Adoptive T-cell therapy: a need for standard immune monitoring.5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies.Differential Phenotypes of Myeloid-Derived Suppressor and T Regulatory Cells and Cytokine Levels in Amnestic Mild Cognitive Impairment Subjects Compared to Mild Alzheimer Diseased Patients.Cancer Immunotherapies: Are They as Effective in the Elderly?CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.

P2860

Q27014189-4AAD3EBE-7535-45A8-B439-E30419BB0918 Q28072712-918348F1-C5DF-40C5-90B6-C3AD90B785C2 Q28075719-D3BEF5A0-AE05-4484-B57E-E5EC2DBABB6E Q33591598-A16A18EA-C2CE-49C7-AD48-3F0EBCFEAD85 Q33653403-8FFDD699-F8F6-4C7A-A493-FDFBD250C59F Q33739465-9C2421E5-187C-4311-AE0E-F8AB41DDABD8 Q33743997-06284CE7-1CEE-4815-8698-6E28B77B15EF Q33889439-4A85300B-AF90-4AD9-93A6-999B91A775B3 Q34250873-ED3421DE-669F-4D64-A6CB-EDD624712048 Q34315871-E8555C2B-0D5D-443F-A052-7AFB74CA04B7 Q34654225-5CFB1DB8-F834-4AFB-9FF3-780A9CE3B142 Q35169807-77E5C382-44AA-4A74-B80B-A9A0B1A1B2A9 Q35178139-B61876A3-E89E-4434-B82D-B36ABDAD2E2C Q35271470-1A63E2A7-9178-4091-B728-1C664FEAD5E7 Q35509317-EABBEA2C-061D-458F-B5C0-5962EE6512EE Q35609094-2BBC298E-73EA-4F30-B1D8-C9BEF08E9405 Q35690250-023B9FD9-7C3A-415C-9322-AD87379F43C0 Q36266655-EC0B1BBB-A46E-4E6E-AA98-E52A8411DD96 Q36456483-05BA225E-4DBA-4F9D-B26A-D9A3CCBA92BC Q36559760-9B5047EA-BE7B-4618-A0FE-4955C9FFA357 Q36683267-8B529974-F8ED-4E58-98D0-257CB0A70190 Q36761567-891B6B4A-9843-40B5-A00C-C18E1CCC4A28 Q36869774-39F73BBC-FC7E-425F-B59D-3A209F778620 Q36902015-407D5582-A22D-4672-A8D8-F011E47D15AB Q36974463-0B35B17A-8C2A-4B07-87BB-93A2BF9A9F3E Q36981510-0655EF4C-50FA-4231-9466-06D9DE0649D6 Q37297526-B2817D3C-8E46-4825-AF54-12410281648C Q37532685-AD466DC7-7F4E-4A5A-83A3-7014883934AC Q37704869-82B3797B-EC55-4307-8F34-C9C2BC6BD97A Q38108390-75ACC466-41B7-456A-9C14-1D0DA448F0F5 Q38116711-B120ABB8-505C-4518-A0BD-451E19F20028 Q38161536-D9DEED78-EA6F-466B-84D8-4AF2192E2B34 Q38204175-DC0CCB13-1EEA-4427-BF69-B691C842BD85 Q38215678-FDB1106E-9F85-4100-9FCF-9C217DA08D28 Q38525029-3F1B8E58-E77A-40DC-975E-739379EA6213 Q38588894-FC2E2872-C3F2-460F-8405-6C58FDDB2243 Q38652940-DDC17B44-B047-49C8-936D-59763B4E047C Q38679662-16012DA5-B874-4F23-BE75-814571D2BFC8 Q38741840-86736230-BC65-4429-93E5-3A61C374578E Q38767735-459C1FE1-570B-42DC-9DEE-EAB98DC77D20

P2860

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

http://www.wikidata.org/entity/Q42219156

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@en

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@nl

type

label

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@en

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@nl

prefLabel

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@en

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@nl

P1433

Q42219156-186BD8BA-5C67-426B-BC0B-CFD45E742B3A

P1476

Q42219156-5082AD02-4CA6-40BC-813A-1C4B29D0A5DD

P2093

Q42219156-1A0E1C8A-F7C4-4E70-A841-8DFA9C1FAF79

Q42219156-2B10502E-054B-4C7A-8096-FBE3FD1A3FB5

Q42219156-3D497D30-92E5-4A81-99DB-0FF040D5D76A

Q42219156-466D9EE0-03EC-4532-9B0A-6CF0C81D067A

Q42219156-5CD70087-16D9-45DC-AF70-B720514C14EF

Q42219156-B1B445B5-6D2D-4B05-9719-CEE1C94F35D5

P2860

Q42219156-07213FC2-DC38-498F-9F74-47BCF333677F

Q42219156-0E75E76E-C57D-4A74-B7C8-641DC146A652

Q42219156-10230BF2-41F5-4600-955E-C38F9F848EBC

Q42219156-20FA2612-96BA-447F-A140-D7918F68E56E

Q42219156-26D48248-0CF5-4297-81F2-191A1FA8A504

Q42219156-35B73333-901D-4D8E-A2F7-D7069BCE24F1

Q42219156-3C8970CC-4C19-4148-8FE5-A8E9FEADBED0

Q42219156-411144D3-0C18-48A9-941C-9611B5B6C29F

Q42219156-420C57A8-3DC7-407D-AA34-6F0D2D91CB23

Q42219156-44F933D5-F403-4C19-8BD2-ACF8BC5F38C6

P304

Q42219156-19BCC2EC-A076-4CD0-9C42-E797AB75E03F

P31

Q42219156-ABE398E4-9EE2-4942-AF3A-6B9C5CE87F78

P356

Q42219156-B3BD572D-31BA-4E9A-A5E5-71947C6E5039

P433

Q42219156-7AD675D3-AB6B-4038-8A5D-E42A8C4F1C41

P478

Q42219156-0EBA8C06-B97E-4D2B-994B-37073BE4A67F

P577

Q42219156-20216E57-CE03-43DD-A83F-F3075D681FE6

P698

Q42219156-6C9D4605-CDA3-4BD3-99F2-CFFB6CACE033

P921

Q42219156-C681BD69-FC0B-4D75-B189-1EB7CC89B94B

P932

Q42219156-29658036-1F32-48F6-80FE-A96AC579703F

P356

J.JIM.2012.04.004

P1433

Journal of Immunological Methods

P1476

Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.

@en

P2093

Athanasios Kotsakis

http://www.w3.org/2001/XMLSchema#string

Athanassios Argiris

http://www.w3.org/2001/XMLSchema#string

Bastian Schilling

http://www.w3.org/2001/XMLSchema#string

Malgorzata Harasymczuk

http://www.w3.org/2001/XMLSchema#string

Theresa L Whiteside

http://www.w3.org/2001/XMLSchema#string

Vasilis Georgoulias

http://www.w3.org/2001/XMLSchema#string

P2860

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression.

Myeloid derived suppressor cells in human diseases

P304

14-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JIM.2012.04.004

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

381

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22522114

http://www.w3.org/2001/XMLSchema#string

P921

cryopreservation

P932

3385927

http://www.w3.org/2001/XMLSchema#string